Notes
Slide Show
Outline
1
NUTRITIONAL MEDICINE AND GASTROINTESTINAL PATHOLOGY
  • Leo Galland, M.D.
  • Foundation for Integrated Medicine
  • www.mdheal.org
2
WHY SPEND A HALF DAY TALKING ABOUT THE GUT?
  • The small bowel is where digestion and absorption of nutrients occurs
  • The food we eat creates the intestinal micro-environment
  • The intestinal microenvironment has an important influence on the pathophysiology of many different diseases
  • Diets don’t treat diseases, they treat patients
3
BEYOND DIGESTION
  • The gut is a sensory organ. Protozoa know their environments by ingestion.
  • The gut is a neuroendocrine organ. Every neurotransmitter found in the brain is also found here.
  • The gut has a brain of its own, an intact and independent nervous system.
  • The gut is the largest organ of immune function in the body; 70% of our lymphocytes live here.


4
BEYOND DIGESTION
  • The gut contents are an inner world that is “outside” the cellular body. Its surface is a frontier with an area 100 meters square and a thickness of one cell
  • Gut flora are an organ that contains as many microbial cells as the cellular body has mammalian cells (100 trillion)
  • -Over 500 species
  • -Over 90% are anaerobic


5
BEYOND DIGESTION
  • The normal intestinal microflora constitute a huge chemical factory that alters our food and our GI secretions
  • The normal intestinal microflora present our immune systems with a mass of antigens that are partially absorbed
6
 
7
 
8
 
9
Intestinal dysbiosis, altered permeability, food intolerance and detoxification are inter-connected parts of the same puzzle


10
MUCOSAL BACTERIA ARE USUALLY NOT ISOLATED
 FROM STOOL
  • Colon:  Anaerobic spirochetes, fusiform bacteria
  • Ileum:  Coccobacilli
  • Stomach:  Lactobacilli, yeasts
  • Oral:  Anaerobes (Corynebacteria, Actinomyces, Bacteroides, Spirochaetes, Fusobacteria and Aerobes:  Streptococcus and Lactobacillus)
11
COMPOSITION OF
NORMAL STOOL FLORA
  • Eubacterium, 26 spp       25.5%
  • Bacteroides, 20 spp       22.6%
  • Bifidobacterium, 8 spp             11.5%
  • Peptostreptoccus         8.9%
  • Fusobacterium, 5 spp                   7.7%
  • Ruminoccus, 11 spp         4.5%
  • Lactobacillus, 7 spp                       2.4%
  • Streptococci         1.6%
  • Clostridia         0.6%
  • Enterobacteriacae         0.5%
12
BENEFITS OF
NORMAL GUT FLORA
  • Synthesize vitamins
  • Synthesize short chain fatty acids
  • Metabolize xenobiotics/toxins
  • Prevent colonization by pathogens
  • Stimulate normal immune system maturation
  • Convert dietary flavonoids to active aglycones
13
NUTRIENTS SYNTHESIZED
BY NORMAL GUT FLORA
  • Biotin
  • Cobalamin
  • Folic acid
  • Pantothenic acid
  • Pyridoxine
  • Riboflavin
  • Vitamin K
  • Butyric acid
  • Amino acids
14
GUT MICROBIAL DETOXIFICATION
  • Demethylate methylmercury
  • Degrade N-nitrosamines
  • Degrade polycyclic aromatic hydrocarbons
  • Degrade aflatoxin B1 (limited)
  • Hydrolyze guanidinosuccinic acid
15
IMMUNOLOGICAL EFFECTS OF NORMAL GI MICROFLORA
  • Stimulate RES activity
  • Increase number of immunocompetent cells
  • Increase immunoglobulin synthesis
  • Increase complement levels
  • May stimulate dysfunctional immune responses


16
HOW NORMAL GI FLORA PROTECTS AGAINST
GI PATHOGENS
  • Synthesis of short chain fatty acids
  • Synthesis of antibiotics
  • Competition for nutrients
  • Induction of a low re-dox potential
  • Deconjugation of bile acids
  • Blockage of adherance receptors
  • Degradation of bacterial toxins
17
POTENTIAL ADVERSE EFFECTS OF NORMAL GUT FLORA
  • Deactivate trypsin, chymotrypsin and intestinal disaccharidases, producing maldigestion
  • Produce ammonia
  • Consume Vitamin B12
  • Deconjugate bile salts





18
POTENTIAL ADVERSE EFFECTS OF NORMAL GUT FLORA
(continued)

  • Increase enterohepatic recirculation of estrogens
  • Activate pro-carcinogens
  • Stimulate dysfunctional immune responses
19
BACTERIAL ENZYMES OF TOXICOLOGICAL SIGNIFICANCE TO THE HOST
20
TOXIC METABOLITES
OF GI FLORA
  • Ammonia from hydrolysis of urea
  • Amines from amino acid decarboxylation
  • Phenols from dietary tryptophan
  • Secondary bile acids
  • Recycled estrogens
  • Nitrites from nitrates
  • N-nitrosamines from nitrates/nitrites
21
AMMONIA
  • Produced by urease from urea in gut
    • Klebsiella, Proteus, Bacteroides, Bifidobacteria
  • Inhibits oxidative metabolism in brain
  • Reduced by low protein diets, by substituting dairy for meat (flora changes)
  • Low colonic pH reverses absorption
  • Rapid transit inhibits absorption
22
AMINES PRODUCED
BY GI FLORA
  • Inactivated by hepatic MAO
    • tyramine
    • octopamine
    • histamine
    • cadaverine
    • putrespecine
    • Piperidine


23
NITROSAMINES
  • From nitrates/nitrites & secondary amines
  • lecithin, choline          dimethylamine
    • lysine              piperidine
    • arginine          pyrrolidine
  • Water, vegetables, cured meats, cheese may contain nitrates, absorbed in jejunum
  • Hypochlorhydria increases formation
24
BILIARY STEROID METABOLISM BY GI MICROFLORA
  • chenodeoxycholate         lithocholate
  • cholic acid                  deoxycholic(DCA)
  • -DCA in feces correlates with colon   cancer incidence
  • -DCA may          20-CH3-cholanthrene
  • Deconjugation of bile salts


25
ESTROGEN METABOLISM
AND GI MICROFLORA
  • conjugation                biliary excretion
  • deconjugation            increased
  •                                         entero-hepatic
  •                                         recirculation
    •             increased blood and urine estrogen
    • Western diet:  higher plasma estrogen, lower stool estrogen
26
TRYPTOPHAN METABOLISM BY GI MICROFLORA
  • tryptophanase             indole, absorbed by colon mucosa, potential carcinogen
  • GI flora            quinaldic acid, 8-OH quinaldic:  bladder carcinogens
  • Aerobes:  E. Coli, Proteus spp
  • Anaerobes:  Bacteroides fragilis, ss. Thetaiotamicron (increased with stress)
27
PRODUCTS OF MICROBIAL CHO FERMENTATION IN GUT
  • Ethanol
  • Butanol
  • D-lactic acid
  • Hydrogen
  • Acetone
  • SCFAs
  • Propanol
  • Acetaldehyde
  • Formic acid
  • CO2
  • Butylene glycol
28
EFFECTS OF SHORT CHAIN FATTY ACIDS
  • Butyrate:  anti-neoplastic, reduces growth of human cancer cells
  • Propionate:  inhibits gluconeogenesis
  • Acetate:  stimulates salt and water absorption
  • All:  anti-bacterial, anti-fungal
    • lower pH = reduced DCA and less NH4 absorption
    • stimulate growth of mucosal cells
29
FACTORS AFFECTING GI FLORA
  • GI secretions:  type, volume, content
    • Enzymes, cells, mucus, pH, re-dox
  • Diet
    • Fiber, fat, protein, CHO
  • Motility and transit time
  • Host immunity
  • Emotional distress
30
DIETARY EFFECTS ON GI FLORA
  • High Fat:  Bacteroides up, Lactobacilli and Enterococci down
  • Vegetarian:  anaerobes down
  • Cellulose:  lower yeasts, Staph, Proteus and Clostridia; also total bacterial count and levels of bacterial enzymes
31
DIETARY EFFECTS ON GI FLORA
(continued)
  • Galactomannans (guar gum & locust bean gum), carboxymethylcellulose:  increase bacterial bio-mass and enzyme levels
  • Unrefined CHO vs refined:  increase bacterial content of ileostomy fluid
  • Wheat bran:  reduces methylmercury toxicity by increasing demethylation by GI flora
32
DIETARY EFFECTS ON GI FLORA
(continued)
  • D-glucaric acid inhibits B-glucuronidase; found in crucifers, citrus, cherry and human urine
  • Low fiber diets  increase bacterial translocation
  • Pectins with high methoxy content:  increase nitroreductase activity; may increase B-glucuronidase


33
SUMMARY OF DIET AND GI FLORA
  • High meat diets induce enzymes that may promote carcinogenesis and the formation of indoles and ammonia
  • High soluble fiber and complex carbohydrate increases fermentation
  • Insoluble fiber decreases carcinogenic enzyme concentrations
  • Phytochemicals may inhibit bacterial enzymes



34
STRESS AND GI MICROFLORA
  • ACTH injection increases jejunal E. coli
  • Cosmonauts lose Bifidobacteria and Lactobacillus before take-off
  • Fear and anger selectively increase Bacteroides fragilis spp, Thetaiotamicron; this increases colonic tryptophanase, which increases skatole and indole production on high meat diets
35
DYSBIOSIS IS
 ECOLOGIC IMBALANCE
  • Disease or dysfunction produced by the interaction between the host and its “normal” flora, organisms of low intrinsic virulence.
36
DYSBIOSIS-ASSOCIATED DISEASES
  • Acne
  • Psoriasis
  • Eczema
  • Food allergy/intolerance
  • Malabsorption syndromes
  • Cancer:  colon/breast
  • Inflammatory bowel disease
  • Irritable bowel syndrome
  • Chronic fatigue syndromes
  • Rheumatoid arthritis
  • Spondyloarthropathies


37
DYSBIOSIS CAUSES DISEASE BY TWO MECHANISMS

  • Microbial enzymes act upon intestinal contents to produce noxious substances
  • Microbial components stimulate dysfunctional immune responses
38
GI MICROFLORA
AND COLON CANCER
  • Large bowel cancer is associated with high fat, high protein, low fiber diets
  • This effect is in part mediated by bacterial enzymes induced by the nature of the diet, the substrates supplied for these enzymes and the carcinogenic products of enzyme activation
39
GI MICROFLORA
AND COLON CANCER
  • Incidence proportional to DCA excretion
    • inversely proportional to Lactobacillus concentration
  • Vegetarians have less cancer and lower bacterial enzymes in stool:  Beta-glucuronidase, nitro-reductase, 7-alpha-dehydroxylase;
    • Lactobacilli lower these when fed to omnivores and prevent colon cancer in rats given dimethylhydrazine
40
GI MICROFLORA
AND COLON CANCER
(continued)
  • High meat diets increase indole and skatole in stool:  inducing bacterial tryptophanase
  • Human fecal mutagen (FCM), a vinyl ether of propanediol, is associated with a Western diet.  Requires bile and low oxygen. Produced by 5 Bacteroides spp
  • High protein diets       high GI ammonia and high fecal pH.  This increases fecal LCFA and bile acid solubility
41
GI MICROFLORA
AND COLON CANCER
(continued)
  • High CHO/fiber diets      high SCFA and low fecal pH.  This decreases fecal LCFA and bile acid solubility
  • Dietary Ca also renders LCFA insoluble
42
DIETARY PREVENTION OF COLONIC DYSBIOSIS
  • Plant-based, high fiber diet
  • Fermented foods, Lactobacilli
  • Crucifers, flavonoid-rich vegetables & fruits
  • Vegetable cellulose, an insoluble fiber
  • Colostrum, a source of lactoferrins
  • -Lactoferrins bind iron, inhibiting the growth of all bacterial species except lactic acid producers


43
SMALL BOWEL BACTERIAL OVERGROWTH
  • produces a different pattern of dysbiosis, associated with carbohydrate/fiber intolerance, bloating, altered bowel habit, fatigue and maldigestion


44
 CAUSES OF UPPER GI BACTERIAL OVERGROWTH
  • Fistulas
  • Diverticulosis
  • Immune deficiency
  • Intestinal giardiasis
  • Tropical sprue
  • Malnutrition
  • Achlorhydria/hypo-chlorhydria
  • Surgical resection/blind loops
  • Stasis from abnormal motility
  • Strictures
45
EFFECTS OF UPPER GI BACTERIAL OVERGROWTH
  • Vitamin B12 deficiency
  • Bile salt dehydroxylation
    • Impairs formation of micelles
  • Formation of hydroxy fatty acids
  • Bile salt deconjugation
    • Increase colonic water secretion
    • Inhibit monosacchardide transport
46
EFFECTS OF UPPER GI BACTERIAL OVERGROWTH
(continued)
  • Inhibition of folate conjugases
  • Increased fecal nitrogen, hypoalbumenia
  • Bacterial degradation of CHO
  • Villi:  blunted and broadened
  • Lamina propria:  increased mononunuclear cells
47
EFFECTS OF UPPER GI BACTERIAL OVERGROWTH
(continued)
  • Mucosal damage by bacterial enzymes
    • Loss of brush border
  • Endotoxemia/antigenemia
  • Liver damage
  • Joint disease
48
BREATH TESTING FOR BACTERIAL OVERGROWTH
  • FALSE POSITIVES
    • Smoking, sleeping, eating
    • Soluble fiber/FOS
    • Rapid intestinal transit
  • FALSE NEGATIVES
    • Colonic hyperacidity (low stool pH)
    • Absence of appropriate flora
    • Delayed gastric emptying
    • Antibiotics


49
BACTERIAL OVERGROWTH IS MORE COMMON THAN SUSPECTED
  • 202 patients with IBS underwent hydrogen breath testing
  • 157 (78%) had SBBO and were treated with antibiotics
  • 25/47 patients had normal breath tests at follow-up
  • Diarrhea and abdominal pain were significantly improved by treatment
50
SBBO AND IBS: CONCLUSIONS
  • Elimination of SBBO eliminated IBS in 12/25 of patients:
  •    48 % of patients with IBS and abnormal breath tests who responded to antibiotics with normal breath tests no longer met Rome criteria for IBS
  • Pimentel M et al, AM J Gastroenterol 2000
51
MANAGEMENT OF UGI BACTERIAL OVERGROWTH INVOLVES DIET, ANTIBIOTICS
  • Low fermentation diet
  • -restrict sugar, starch, soluble fiber
  • Antimicrobials (in select cases):
    • Metronidazole (anaerobes)
    • Tetracyclines (anaerobes)
    • Ciprofloxacin (aerobes)
    • Bismuth
    • Bentonite



52
Low Fermentation Diet
  • Basic diet: no wheat, sucrose, lactose
  • Additional restrictions
  • -no glutinous grains
  • -no cereal grains, potatoes
  • -restrict fruits, juices, honey
  • -avoid legumes
  • -cook all vegetables
53
IRRITABLE BOWEL SYNDROME
IS ASSOCIATED WITH SPECIFIC FOOD INTOLERANCE
  • Specific food intolerance, present in 48% of patients with diarrhea and pain, is associated with unstable fecal flora, high aerobe:anaerobe ratios and high stool PGE2 levels


  • Alun Jones et al, Lancet, 1982


54
The Addenbrooke’s Hospital Exclusion Diet for IBS
  • 1-2 meats:
  • lamb, turkey, fish, chicken, beef
  • 1 fruit:
  • pears, pineapple, banana, apple
  • Rice, water
  • Commonest diet was lamb, pears, rice




55
Outcome of Exclusion Diet in 182 IBS Patients
  • No improvement after 7 days: 38 (21%)
  • Improved after 7 days: 144 (79%)
  • -Provoking foods identified, established
  • dietary control of IBS: 122 (67%)
  • -Intolerant of one food      5%
  • -Intolerant of 2-5 foods   28%
  • -Intolerant of 6-10 foods 35%
  • -Intolerant of > 10 foods  32%
56
Foods Provoking IBS
  • Tea   25%
  • Butter 25%
  • Yogurt 24%
  • Citrus 24%
  • Barley 24%
  • Chocolate 22%
  • Nuts 22%
  • Preservatives 20%
  • Wheat 60%
  • Milk 44%
  • Corn 44%
  • Cheese 39%
  • Oats 34%
  • Coffee 33%
  • Rye 30%
  • Eggs 26%


57
Foods Provoking IBS
  • Pork 14%
  • Broccoli 14%
  • Soy 13%
  • Chicken 13%
  • Spinach 13%
  • Yeast 12%
  • Lamb 11%
  • Sugar 12%
  • Potatoes 20%
  • Cabbage 19%
  • Sprouts 18%
  • Peas 17%
  • Beef 16%
  • Carrots 15%
  • Lettuce 15%
  • Rice 15%



58
Food Intolerance in IBS Is not Associated with Atopy
  • Only 10% of patients were atopic
  • 40% could relate onset of symptoms to:
    • -A course of antibiotics (11%)
    • -A bout of gastroenteritis (12%)
    • -Abdominal or pelvic surgery (15%)
  • Unstable fecal flora was common
  • Hunter et al,Topics in Gastroenterology, 1985
59
IBS with Food Intolerance Is Associated with Excess Fermentation, Corrected by Diet

  • 6 patients, 6 controls, whole body chamber
  • Total body hydrogen production greater with IBS, fell with exclusion diet. (No grains except rice, no dairy or beef, restrict yeast, citrus, caffeine, tap water)
  • King et al, Lancet 352: 1187-1189 (1998)
60
 
61
IMMUNE SENSITIZATION AND DYSBIOSIS
  • Immune responses to intestinal microorganisms may provoke inflammatory and auto-immune disorders
  • Specific:  bacterial antigens mimic auto-antigens
  • Non-specific:  polyclonal activation, RES hyperstimulation, APC activation
62
MOLECULAR MIMICRY
(Cross Reactivity)
  • MECHANISM
  • Microbes colonize positive individuals
  • Cross-reactivity with bacterial antigens leads to secondary immune damage
  • Antibodies against microbes bind to cells carrying HLA antigens
  • Increased cytotoxic damage
  • Inflammation from complement or cytokine cascades
63
INTESTINAL INFLAMMATION AND SPONDYLOARTHOPATHIES
  • sIgA is increased in AS (suggest enteritis)
  • Sub-clinical ileitis occurs in many pts with primary spondyloarthropathies
  • 10-20% of IBD patients get AS
  • Bowel infections often precede reactive arthritis
  • Silent carriage of Salmonella can precipitate reactive arthritis
64
KLEBSIELLA AND ANKYLOSING SPONDYLITIS (AS)
  • MOLECULAR MIMICRY


  • Klebsiella antigens cross-react with HLA-B27
  • Initiates inflammatory cascade
    • Leads to reactive arthritis
65

KLEBSIELLA AND ANKYLOSING SPONDYLITIS (AS) (continued)
  • THE EBRINGER RESEARCH


  • 96% of AS patients have HLA-B27 gene
  • Many AS patients grow Klebsiella on stool culture
  • AS pts have higher serum IgA against Klebsiella than controls


66
Nutritional Therapy for Ankylosing Spondylitis
  • A diet free of grains and disaccharides reduced levels of Klebsiella in stool, lowered the level of anti-Klebsiella IgA and improved the symptoms of patients with AS


  • Ebringer, Balliere’s Clin Rheumatol, 1989
67
VS, 41 year old male event planner with hip, knee and back pain and fatigue
  • Prior history: chronic rhinitis, hypercholesterolemia, Lyme disease 1993 and 1994, hypothyroidism 1994
  • Past several years: persistent tightness in back, persistent pain in calves,hips, knees, poor response to physical therapy, fluctuating fatigue, poor sleep, dizziness, alternating constipation and diarrhea.
  • Food: single, lives alone,eats out all the time, sweets.
  • Family history: Crohn’s disease, hyperlipidemia, hypertension. Mother had been ill with ASVD and breast cancer most of his life.



68
VS, 41 year old male event planner with hip, knee and back pain and fatigue
  • Physical exam:
  •   -Nodular thyroid
  •   -Decreased range of motion of hips and LS spine, diminished straight leg raising bilaterally, no joint tenderness, scattered tender points of lower extremities
  • Lab:
  • - HLA B27 +
  • -ANA + 1:40 speckled
  • -Normal X-rays of SI joints, spine
  • -E. histolytica in stool
69
VS, 41 year old male event planner with hip, knee and back pain and fatigue
  • Treatment:
  • -Ebringer diet (eliminate grains, sucrose, lactose)
  • -Doxycycline, paromomycin
  • Initial response:
  • - “I can’t prepare my own food.”
  • - Hip and knee pain markedly improved.
  • - Lost 20 lbs.
  • Further response:
    • “My friends can’t believe that I’m cooking for myself.”
    • “My friends can’t believe how good I look.”
    • “My physical therapist can’t believe how flexible I am.”
    • 90% pain-free, modifies diet to his life style.
70
PROTEUS AND RHEUMATOID ARTHRITIS (RA)
  • Frequency of HLA-DR4 in RA patients:  50 to 75%. Those without HLA-DR4 usually have DR-4 + mothers.
    • Controls:  20% HLA-DR4 positive
  • RA patients often have elevated serum IgG titers to Proteus spp that cross-react with HLA-DR4
71
Proteus, RA and Diet
  • RA patients in England, Spain and Norway have higher anti-Proteus IgG than controls
  • Anti-Proteus IgG correlates with disease activity and C-reactive protein levels
  • Fasting, followed by a one year gluten-free vegan diet improves symptoms and indices of disease activity, only in patients whose Proteus antibodies decrease and who show a change in fecal bacterial fatty acid profiles. E coli antibodies are not affected
72
SKIN DISEASES
AND THE GI FLORA
  • Cystic acne: endotoxemia
  • Atopic eczema:  dramatic reduction of Lactobacilli, Bifidobacteria, Enterococci; increased Candida, Clostridia, Staph aureus, Proteus, Klebsiella, atypical coliforms
  • Psoriasis, scalp seborrhea: intestinal yeasts


73
DYSBIOSIS MAY INVOLVE YEASTS AND PROTOZOA
  • Yeasts are normal inhabitants of the alimentary canal and are glucose fermenters
  • Yeasts are powerful chemical factories
  • Yeasts are highly antigenic
  • -90% of people have type 4 immunity
  • -10% of people have type 1 immunity
  • -type 3 immunity was found in asthmatics
  • Yeast polysaccharides exert immune activating (zymosan) and immune suppressing (mannan) activity


74
GUT FERMENTATION
AND YEAST
  • (Hunnisett et al, J Nutr Med 1990)
  • 61% of chronically ill polysymptomatic patients developed measurable ethanol in blood after ingesting 6 gm glucose
  • Mean rise of 2.5 mg/dl, range from 1 to 7
75
TREATMENT RESULTS SUGGEST YEAST AS A CAUSE OF FERMENTATION AND SYMPTOMS
  • Low sugar diet cleared 42%
  • Diet + nystatin cleared 86%
    • 116/149 clinically better
  • Diet + tetracycline cleared 21%, worsened 35%
    • 2/22 clinically better
76
AS, 31 year old woman with angioedema
  • Prior: Recurrent yeast vaginitis, SAR
  • 1999: OCP for one year, tetracycline for acne for one month      edema of face, feet, fingers, hives. Oral steroids.
  • 2000-2001: edema, urticaria, fatigue, brain fog—50% of time. Antihistamines ineffective. Diuretics prn. Allergy evaluation: neg.
  • Self-started a yeast elimination diet: “less moody, a bit less swollen”.
77
AS, 31 year old woman with angioedema
  • Physical exam: mild acne with scarring, peri-orbital swelling, angioedema of left palm, distended abdomen with LLQ tenderness, normal genitalia
  • Intradermal C. albicans antigen: marked delayed reaction, starting after 6 hours, lasting for several days with diffuse erythema, edema and tenderness of forearm, healing with scaling of skin
  • Lab: impaired lymphocyte proliferative response to C. albicans (1.2, ref>3), low plasma zinc (597 mcg.dL, ref 600-1300), borderline retinol 39 mcg/dL (ref 38-106)
78
AS, 31 year old woman with angioedema
  • Treatment:
    • Continue diet
    • Zinc 25 mg/day
    • Vitamin A 10,000 IU/day
    • Lactobacillus plantarum 10 billion units/day
    • Nystatin 3 million units p.o. tid.
      • Initial response was more swelling, lip edema
      • Raised dose to 13 million units/day       diuresis, followed by clearing of edema and increased energy
79
NOMENCLATURE
  • CHRONIC CANDIDIASIS
  • CANDIDA SENSITIZATION SYNDROME
  • POLYSYSTEMIC CHRONIC CANDIDIASIS
  • YEAST SYNDROME
  • YEAST PROBLEM
  • YEAST DISEASE
  • CANDIDA
  • “THIS PROBLEM”


  •      CANDIDA-RELATED COMPLEX (CRC)


80
CRC:  SYMPTOMS
  • MUCOSAL INFECTION
  • FATIGUE
  • DEPRESSION
  • PMS
  • G.I. DISTURBANCES
  • POOR CONCENTRATION/MEMORY
  • ALLERGIC REACTIONS
  • ORGAN SPECIFIC
  •          SKIN RASH, ECZEMA, URTICARIA
  • HEADACHE
  • OTHER


81
INTESTINAL YEASTS MAY CAUSE SYMPTOMS BY 3 MECHANISMS
  • Tissue invasion (oral, esophageal, intestinal thrush)
  • Fermentation of sugars (production of ethanol, arabinitol and other toxins)
  • Sensitization (asthma, urticaria, allergic vaginitis, IBS, Crohn’s disease, psoriasis). Cross-sensitization with food yeast may occur
82
CRC IS RELATED TO THE HOST-YEAST INTERACTION
  • Rectal cultures of patients who respond to anti-fungal drugs are less likely to grow yeasts than those of a normal population
  • These patients produce mucosal factors that are abnormally active at inhibiting yeast growth
83
 
84
 
85
 
86
COMPARISON STUDY 
87 PATIENTS:  42 CRC+/45 CRC-
  • POSITIVE RECTAL YEAST CULTURE (41)
  • 10 CRC+/31CRC-
  • NEGATIVE RECTAL YEAST CULTURE (46)
  • 32 CRC+/14 CRC-
  • POSITIVE SMEAR (37)
  • 32 CRC+/5 CRC-
  • NEGATIVE SMEAR (9)
  • 0 CRC+/9CRC-
87
CRC:  RETROSPECTIVE STUDY
  • YEAST SEEN IN RECTAL SWABS
  • PRE-TREATMENT SMEAR  (CALFLOR STAIN)
  • 0-trace 0
  • + 4
  • ++/+++        36


  • POST-TREATMENT SMEAR  (CALFLOR STAIN)
  •      0-trace        28
  • + 0
  • ++/+++ 3
88
CRC:  RETROSPECTIVE STUDY
  • MICROBIOLOGY OF RECTAL SWABS
  • PRE-TREATMENT CULTURES (BIGGY AGAR)
  • POSITIVE 11
  • NEGATIVE 32


  • 31 PATIENTS WITH CRC HAD A RECTAL SMEAR THAT WAS ++/+++ AND A SIMULTANEOUS RECTAL CULTURE THAT WAS NEGATIVE (78% OF TOTAL WITH PRE-TREATMENT SMEARS & CULTURES)
89
"Patients with CRC who had..."
  • Patients with CRC who had strongly positive rectal mucus smears and negative rectal cultures had something in their mucus that inhibited the growth of Candida albicans in culture
90
 
91
 
92
TREATMENT OF YEAST DYSBIOSIS INVOLVES DIET AND MEDICATION
  • Sugar restriction
  • Avoidance of dietary yeasts (fermented foods, dried fruits, fruit juices, bread)
  • Anti-fungal medication (may provoke a Herxheimer-type response before symptoms improve)
  • Restoration of normal bacterial flora with pro-biotic supplements
93
THE SPECTRUM OF DISEASE INDUCED BY INTESTINAL PARASITES
  • Diarrhea, dysentery, enteritis, colitis
  • “Non-specific” chronic GI complaints
  • UGI bacterial overgrowth
  • Extra-intestinal tissue invasion
  • Malabsorption syndrome
  • Immune supression
  • Allergy (urticaria, atopic reactivity)
  • Food intolerance
  • Fatigue
  • Rheumatologic syndromes
94

MECHANISM OF SYSTEMIC EFFECTS OF INTESTINAL PARASITES
  • Increased intestinal permeability
  • Immune sensitization/suppression
  • Malabsorption
95
PARASITIC RHEUMATISM
  • Inflammatory arthropathy
  • Elevated ESR
  • Inconsistent eosinophilia
  • Inefficacy of anti-inflammatory drugs
  • Demonstration of parasitic infection
  • Prompt response to anti-parasitic treatment
  • Immune complex formation
96
INTESTINAL PARASITES CAUSING PARASITIC RHEUMATISM
  • Giardia lamblia
  • Entamoeba histolytica
  • Endolimax nana
  • Taenia Saginata
  • Schiostosoma mansoni
  • Ascaris lumbricoides
  • Strongyloides stercoralis
97
A UNIQUE ROLE FOR INTESTINAL HELMINTHS
  • Stimulate development of TH-2 cells and down-regulate TH-1 cells
  • Stimulate production of the anti-inflammatory cytokine IL-10
  • Lack of helminths may account for the increasing prevalence of inflammatory disorders in the developed world, both atopic and mediated by TH-1 autoimmunity
98
LACTOBACILLI: 
BENEFICIAL EFFECTS
  • Produce organic acids:  lower bowel pH
  • Produce H202
  • Antagonize enteropathogenic E. Coli, Salmonella, Staphylococci, Candida albicans, and Clostridia spp
  • Degrade N-nitrosamines
  • Anti-tumor glycopeptides (L. bulgaricus)
  • Stimulate balanced immune responses
99
Lactobacilli for Prevention of Food Allergy in Infants
  • DBPCT: Lactobaciilus GG given to high risk mothers during last 2 weeks of pregnancy and for 6 months after birth to their offspring
  • Atopic eczema at 2 years
    • Controls: 31/68 (46%)
    • Lactobacillus 15/64 (23%), RR=0,51


    • Kalliomaki et al, Lancet 357: 1076-79 (2001)


100
Lactobacilli for Managing Food Allergy
  • Infants with atopic eczema and cow’s milk allergy fed hydrolyzed whey formula with or without Lactobacillus GG
  • -Clinical improvement associated with  95% decline in fecal TNF-alpha in the Lactobacillus group, signifying reduced GI inflammation
  • Majamaa, Isolauri, J All Clin Immunol 1997
101
BENEFITS OF
BACILLUS LATERSPORUS
  • Laterosporamine:  antibiotic
    • Suppress auto-antibody formation
    • Suppress murine lupus nephritis
  • Spergualin:  anti-tumor, antibiotic
102
BENEFITS OF SACCHAROMYCES BOULARDII
  • Stimulates production of sIgA
  • Protects against antibiotic diarrhea
  • Helps reverse C difficile colitis
103
E. COLI:  BENEFICIAL EFFECTS
  • Prevents infection of animals with Cholera, Shigella, Pseudomonas and staph aureus (no effect on Candida or Salmonella)
  • Degrades N-nitrosamines and polycyclic aromatic amines and N-hydroxyl aryl amines
104
E.COLI AND ULCERATIVE COLITIS
  • E. coli in colonic crypts of UC patients shows abnormal adherence
  • Burke, Axon J Clin Path 40: 782-786 (1987)


  • After inducing remission with gentamycin and prednisone,Nissle 917 strain E. coli were as effective as mesalamine in maintaining remission at 12 months
  • Rembacken et al, Lancet 354: 635-640 (1999)


105
EPITHELIAL PERMEABILITY REGULATES TRANSPORT OF WATER, SOLUTES AND PARTICULATE MATTER

  • “The intestinal epithelium is the site of vectorial transport…between the intestinal lumen and the circulation. The net effect of transport is regulated by the tightness (or leakiness) of the barrier and vice versa. Both transport and barrier functions are physiologically regulated, and both can be dramatically altered under disease conditions.”
106
MECHANISMS WHICH SUPPORT
NORMAL INTESTINAL PERMEABILITY
  • Intestinal mucus
  • Secretory IgA
  • Mucosal epithelium
  • Intramural macrophages
  • Intramural lymphocytes
    • intra-epithelial
    • in Peyer’s patches
107
TWO TYPES OF
EPITHELIAL PERMEABILITY

  • Trans-Cellular


  • Para-Cellular
108
 
109
TRANS-CELLULAR PERMEABILITY
  • The principal route for the absorption of solutes, fluid and macromolecules
110
ACTIVE TRANSPORT
  • Monosaccharides
  • Amino acids, peptides
  • Sodium, zinc, copper, iron, calcium
  • Vitamins
111
NUTRIENT ABSORPTION
BY DIFFUSION
  • Magnesium
  • Free fatty acids
  • Monoglycerides, lysolecithin
112
ENDOCYTOSIS
  • Micelles
  • Macromolecules
  • Antigens
  • Microbes


113
INTESTINAL ANTIGEN TRANSPORT IS A PHYSIOLOGICAL PROCESS
  • M-Cells
    • Particulate/insoluble antigens
    • Overlie Peyer’s Patches
    • Response is mostly CD4
  • Enterocytes
    • Soluble antigen
    • Response is mostly CD-8
114
 
115
 
116
INCREASED
TRANS-CELLULAR PERMEABILITY
  • Results from impairment of mucosal metabolism
  • Represents a breakdown in the normal activity known as “Gut Antigen Sampling”
117
PARA-CELLULAR PERMEABILITY IS LIMITED BY CELL ADHERANCE MOLECULES (CAMs)
  • Tight junctions contain claudins
  • Adherens junctions and desmosomes contain cadherins
  • Contraction of the cytoskeleton opens junctions (glucose absorption is a stimulus)


118
 
119
CAUSES OF INCREASED
PARA-CELLULAR
PERMEABILITY
  • Infectious agents
    • Parasites
    • Bacteria
    • Viruses
    • Yeasts
    • Continued
120
CAUSES OF INCREASED
PARA-CELLULAR PERMEABILITY

  • Enterotoxins
    • Ethanol
    • NSAIDs
    • Cytotoxic drugs
  • Dysoxia
    • Ischemia
    • Reactive oxygen species
121
PSYCHOLOGICAL STRESS CAN INCREASE GUT PERMEABILITY THROUGH A CHOLINERGIC MECHANISM
  • Rats: cold stress increases both para-cellular permeability and endocytosis.
  • -This effect is greater when cholin-       esterase activity is weak
  • -The effect is blocked by atropine
  • -It may depend upon vagal activation of   mast cells
  • Similar effects occur in humans
122
DIET ALTERS INTESTINAL PERMEABILITY
  • Fasting:
    • Controls:  Increased I.P.
    • R.A.:  Decreases I.P.



    •       Continued
123
"Increased I.P"
  • Increased I.P. induced by:
    • Low-fiber diets
    • Carrageenan
    • Pectin/guar gum
    • Castor oil
    • Alcohol
    • Allergens


    •                                                                        Continued



124
"Mucosal Inflammation"
  • Mucosal Inflammation
    • Food allergy
    • “Idiopathic”
125
EFFECTS OF
INCREASED PERMEABILITY
  • Antigen Overload
    • Sensitization
    • Immune suppression
  • Toxic Overload
    • Hepatic stress
  • Sepsis
126
INTESTINAL PERMEABILITY IS MEASURED BY PROBES ABSORBED AND EXCRETED UNCHANGED BY THE KIDNEYS

  • Probes used for small bowel permeability include Cr51-EDTA, PEGs and the ratio of lactulose to mannitol.
  • Colonic permeability can only be measured if the probe is administered by enema.
127
INCREASED INTESTINAL PERMEABILITY (LEAKY GUT) IS NOT A DISEASE OR SYNDROME

  • It contributes to the pathophysiology of many different diseases.
  • Improvement of the related disease usually improves the leaky gut.
  • Decreased intestinal permeability often improves the associated disease.
128
LEAKY GUT SYNDROMES
  • CFIDS
  • MCS
  • Chronic pancreatic disease
  • Chronic non-infectious hepatitis
  • Acne
  • psoriasis
  • Enteritis, colitis Infectious/inflam-matory
  • Arthritis, chronic inflammatory
  • Food allergic disorders
  • AIDS


129
THE FOUR VICIOUS CYCLES OF THE LEAKY GUT
  • Food Allergy
  • Malnutrition
  • Dysbiosis
  • Hepatic Distress
130
CYCLE ONE:  FOOD ALLERGY
  • Increased baseline permeability
  • Marked increase after challenge
  • Increase blocked by sodium cromoglycate
131
ABNORMAL INTESTINAL PERMEABILITY IN
FOOD ALLERGY
  • 42% of children with eczema had reduced        jejunal villus:crypt ratios (malabsorption)
  • Increased PEG-4K absorption (leakiness)
  • Increased PEG absorption blocked by cromolyn pre-treatment
  • Increased fasting lactulose absorption in adults with food allergy (eczema, hives); further increase with offending food blocked by cromolyn 300mg


132
"“Evaluation of I.P"
  • “Evaluation of I.P… provides an effective means of diagnosing food allergy”
  • Barau E and Dupont C, Modifications
  • of Intestinal Permeability during Food
  • Provocation Procedures in Pediatric
  • Irritable Bowel Syndrome,
  • J Pediatr Gastroenterol Nutr, 11:72-77,
  • 1990


  •                                                                                    Continued


133
"17 children with IBS"
  • 17 children with IBS
  • 9 with with food-induced alterations of intestinal permeability
  • All 9 were completely cured with diet (7 diet alone, 2 diet plus oral cromolyn before meals)
134
"After ingesting food allergens"
  • After ingesting food allergens, lactulose/mannitol (L/M) ratios rose significantly


  • Taking sodium cromoglycate prevented the rise in L/M ratios



  •                                                                      Continued
135
 
136
 
137
CYCLE TWO:  MALNUTRITION
  • Most nutrients require active transport
  • Factors which increase I.P. may hinder active transport
  • Resulting malnutrition disrupts intracellular adhesion
138
CYCLE THREE:  DYSBIOSIS
  • Bacterial proteases disrupt cellular adhesion molecules
  • Increased I.P. leads to bacterial sensitization
  • Bacterial sensitization causes leukocyte migration which increases permeability
139
 
140
CYCLE FOUR:
 HEPATIC DISTRESS
  • Increased permeability causes:
  • Toxic stimulation of mono-oxygenases
  • Increased free radical generation
  • Damage to hepatocytes and bile ducts
141
"Biliary excretion of reactive oxygen..."
  • Biliary excretion of reactive oxygen species
  • Reflux of toxic bile into pancreatic ducts
    • Loss of factors
    • Pancreatic insufficiency
  • Toxic bile enteropathy
142
HEPATIC COST OF INCREASED PERMEABILITY
  • Kupffer’s Cell Paralysis
  • Stimulation of Mono-Oxygenases
  • Depletion of substrates for conjugation
    • GSH, Glycine


    •                                                                    Continued
143
HYPER-PERMEABILITY
IN RHEUMATOID ARTHRITIS
  • NSAIDs increase intestinal permeability
  • Increased I.P. allows sensitization to gut flora
  • Bacterial sensitization causes enteritis and formation of circulating immune complexes
144
HYPER-PERMEABILITY
IN RHEUMATOID ARTHRITIS
(continued)
  • I.P. is further increased
  • Systemic inflammation exacerbates
  • Metronidazole and minocycline break the cycle


145
TREATMENT OF
HYPER-PERMEABILITY
  • Avoid enterotoxins
  • Treat intestinal infection/bacterial overgrowth with antimicrobials
  • Diet:  high nutrient density
    • non-irritating
    • allergen-free
146
HELPING TO REPAIR THE DAMAGED INTESTINE
  • Glutamine
  • Essential fatty acids
  • Antioxidants
    • Glutathione
    • Bioflavonoids
    • Vitamin E
    • Gamma-oryzanol
  • Epidermal growth factor
147
A.F., a 6 year old girl with fever of unknown origin
  • Prior history: vesicoureteric reflux and recurrent UTI; used co-trimoxazole from 12 to 36 months of age and it cleared.
  • Age 5 developed cycling fever with daily temperature spikes to 105 F, lasting 5 days and recurring every 10 to 21 days.
  • Appendectomy (normal appendix) followed by 2 months of metronidazole in September 1998. Microscopic colitis was found in transverse colon, not though to be Crohn’s or ulcerative colitis.
  • Fevers continued but with decreased severity and frequency
148
A.F., a 6 year old girl with fever of unknown origin
  • Parents started a diet eliminating sugar, junk food, wheat and milk products, with improvement:
  • -Fevers occurring every 5 to 7 weeks, lasting only 3 days, spiking only to 102 F. In between fevers, patient appears very healthy. ESR 38 with fever
  • Seen in July 1999.
  •       ESR 16 (afebrile)
  •       intestinal permeability: low mannitol excretion (3%), high lactulose/mannitol ratio (0.313)
  •       IgG to casein in blood, not to gluten
149
A.F., a 6 year old girl with fever of unknown origin
  • Treatment:
  • -casein-free diet
  • -L-glutamine 3.7 gm bid
  • -microcrystalline cellulose 3.7 gm bid
  • -N-acetyl-glucosamine 185 mg bid
  • - Ulmus rubra bark (slippery elm) 110 mg bid
  • -Methylsulfonylmethane (MSM) 160 mg bid
  • -Aloe vera extract (30% MPS) 1 tsp qd
  • Mixed together in apple sauce
150
A.F., a 6 year old girl with fever of unknown origin
  • Initial response:
  • -“Radiant and happy, energy better than in her whole life”
  • - No fever until April, 2000, following Easter festivities:
  • -Temp 102 F, lasting 2 days, recurred 3 weeks later.
  • -Intestinal permeability: low mannitol excretion (3%),    lactulose/mannitol ratio improved at 0.107
  • Advised to follow casein-free diet 100% for at least a month
  • Further response:
  • -No fever during subsequent year
  • -Normal intestinal permeability by 10/00. Mannitol excretion 12%, lactulose mannitol ratio 0.04.
  • -Glutamine, NAG, MSM, slippery elm, aloe discontinued.
  • -Able to tolerate casein when away from home.


151
INTESTINAL PERMEABILITY
AND CROHN’S DISEASE
  • Patients have increased I.P.
  • First degree relatives have high I.P.
  • Patients have abnormal reactivity of mucosal lymphocytes to normal gut flora and Candida antigens



152
"For patients in remission"
  • For patients in remission, the rate of relapse correlates with I.P. measured prospectively


  • Wyatt J et al, Intestinal Permeability and the Prediction of Relapse in Crohn’s Disease, Lancet 341:1437-1439, 1993
153
 
154
 
155
NUTRITIONAL THERAPY FOR CROHN’S DISEASE
  • 20 patients, age 21 to 59, ill 6 mo to 12 yrs followed for 6  months to 8 years
  • symptoms scored: diarrhea, abdominal pain, fever, fatigue, blood/mucus in stool, weight
  • lab tests scored: hemoglobin, ESR, albumen, intestinal permeability (lactulose/mannitol fractional excretion)


156
THE SPECIFIC CARBOHYDRATE DIET
  • EAT fruits, vegetables, meat, fish, poultry, eggs, nut flours and butters, most legumes, eggs, some hard cheeses and yogurts
  • AVOID all grains, disaccharides (lactose and  sucrose), soy, potatoes


157
DIETARY SUPPLEMENTS
STAGE I
  • Fish oil, delayed release, supplying 875 mg of eicosapentaenoic acid (EPA)/ day
  • vitamin E 400 mg/day
  • zinc 20 mg/ day
  • selenium 200 mcg/day
  • folic acid 800 mcg/day
158
STAGE II DIET OPTIONS
  • complete milk avoidance
  • yeast/mold elimination diet
  • avoidance of nuts and nut flours
  • addition of non-glutinous starch (e.g., rice and potatoes)
  • As modifications to the Specific Carbohydrate Diet
159
STAGE II SUPPLEMENTS
  • glutamine 3000 mg/day
  • Aloe vera mucopolysaccharide concentrate (ace mannan) 4 grams/day
160
CLINICAL RESPONSES
  • complete clinical remission                     6
  • reduction in symptom scores                 14  range 90% to 40%, mean 65%
  • response to Stage I diet                          11
  • response to yeast/mold diet                      5
  • response to milk elimination  diet              5
  • required elimination of nuts                       4
161
SYMPTOM SCORES
162
SEDIMENTATION RATE
163
INTESTINAL PERMEABILITY
  • Lactulose/mannitol ratio, ref range is 0.01 to 0.06
  • measured in 13 patients
  • decreased in 84%
  • initial mean 0.275 (range 0.024 to 0.645)
  • final mean 0.074 (range 0.018 to 0.186)
164
SERUM ALBUMEN
  • Mean serum albumen increased
  • initial: 32 G/L (range 24 to 38)
  • final 41 (range 28 to 46)
165
MEDICATION USE
  • ASA derivatives (16 patients), mean dose decreased 33%
  • prednisone (6 patients), mean dose decreased from 17 mg/day (range 10 to 40) to 5 mg/day (range 0 to 7.5)
  • azathioprine (3 patients), mean dose decreased from 100 mg/day to 33 mg/day (range 0 to 50)
166